Microalbuminuria in essential hypertension

J Nephrol. 1997 Jul-Aug;10(4):216-9.

Abstract

Some patients with essential hypertension manifest increased urinary albumin excretion (UAE). Hypertensive patients with microalbuminuria manifest abnormal circadian variation of blood pressure, increased serum levels of LDL-cholesterol and lipoprotein(a), a greater rise of serum insulin in response to an oral glucose tolerance test, and greater thickness of the carotid artery than patients without microalbuminuria. A 7 year follow-up of 141 hypertensive patients, 54 with microalbuminuria and 87 without microalbuminuria, we observed 12 cardiovascular events in patients with microalbuminuria and only 2 events in the patients with normal urine albumin excretion (P < 0.0002). Creatinine clearance decreased more in patients with microalbuminuria than in those with normal UAE. In conclusion, hypertensive individuals with microalbuminuria manifest a greater incidence of cardiovascular events and more decline in renal function than patients with normal UAE. We propose that measurements of UAE may be a useful marker for cardiovascular risk in patients with essential hypertension.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Albuminuria / complications*
  • Albuminuria / pathology
  • Biomarkers / urine
  • Blood Pressure
  • Carotid Stenosis / pathology
  • Circadian Rhythm
  • Cohort Studies
  • Creatinine / urine
  • Follow-Up Studies
  • Glucose Tolerance Test
  • Humans
  • Hypertension / pathology
  • Hypertension / urine*
  • Insulin Resistance
  • Lipoproteins / blood
  • Predictive Value of Tests
  • Prognosis
  • Retrospective Studies

Substances

  • Biomarkers
  • Lipoproteins
  • Creatinine